Top journals
Frequent coauthors
- Anwer S 1
- Bujkiewicz S 1
- Palmer S 1
- Sofia Dias 1
- Singh J 1
- Saramago P 1
- Thomas A 1
2025
BackgroundMulti-indication cancer drugs receive licensing extensions to include additional indications, as trial evidence on treatment effectiveness accumulates. We investigate how sharing information across indications can strengthen the i…